BLFS

Biolife Solutions Stock Analysis

AI Rating

Neutral
  • Quality4/10
  • Growth↑ 7/10
  • Momentum↓ 3/10
Biolife Solutions sales and earnings growth
BLFS Growth
Good
  • Revenue Y/Y↑ 38.58%
  • EPS Y/Y↑ 68.79%
  • FCF Y/Y↓ -108.29%
Biolife Solutions gross and profit margin trends
BLFS Profitability
Neutral
  • Gross margin ↑ 78.90%
  • EPS margin↓ -4.30%
  • ROIC↓ -4.50%
Biolife Solutions net debt vs free cash flow
BLFS Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -2.6

Biolife Solutions stock volatility is in-line with the overall market. We give it a Great risk rating.

More Medical Instruments & Supplies stocks ↗